Written by The Ophthalmic Viscoelastic Devices Market is expanding as the demand for ophthalmic surgical procedures continues to increase worldwide. Ophthalmic viscoelastic devices are used during eye surgeries to maintain space within the eye and protect delicate intraocular tissues. MRFR’s current market analysis estimates the market at USD 3.24 billion in 2025 and projects it to reach USD 5.53 billion by 2035, representing a CAGR of 5.50%.
Growing cataract surgery volumes are an important factor supporting market development. OVDs are widely used during cataract procedures, including phacoemulsification and intraocular lens implantation. The products can help maintain the anterior chamber and protect ocular structures during surgery. Increasing demand for advanced ophthalmic procedures is therefore creating continued opportunities for OVD manufacturers.
The market includes different product categories, including hydrophobic, hydrophilic, and combination formulations. Cohesive and dispersive properties are important characteristics of viscoelastic materials, with different formulations selected according to surgical requirements. Hospitals, ambulatory surgical centers, and ophthalmic clinics represent key end users of these products.
Regional opportunities are supported by increasing healthcare expenditure, aging populations, and improvements in ophthalmic infrastructure. North America, Europe, Asia-Pacific, South America, and the Middle East and Africa are covered in the market analysis. Continued development of ophthalmic surgery technologies and increasing access to cataract and other eye procedures are expected to support market expansion through 2035.
Dive into related studies for a broader industry perspective:
Central Nervous System Therapeutics Market Growth
Dystrophic Epidermolysis Bullosa Treatment Market Demand